Cargando…
Neonatal Diabetes Mellitus
Neonatal diabetes is a rare cause of hyperglycemia in the neonatal period. It is caused by mutations in genes that encode proteins playing critical roles in normal functions of pancreatic beta cells. Neonatal diabetes is divided into temporary and permanent subtypes. Treatment is based on the correc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315067/ https://www.ncbi.nlm.nih.gov/pubmed/32595377 http://dx.doi.org/10.14744/SEMB.2017.51422 |
_version_ | 1783550183853785088 |
---|---|
author | Zübarioğlu, Adil Umut Bülbül, Ali Uslu, Hasan Sinan |
author_facet | Zübarioğlu, Adil Umut Bülbül, Ali Uslu, Hasan Sinan |
author_sort | Zübarioğlu, Adil Umut |
collection | PubMed |
description | Neonatal diabetes is a rare cause of hyperglycemia in the neonatal period. It is caused by mutations in genes that encode proteins playing critical roles in normal functions of pancreatic beta cells. Neonatal diabetes is divided into temporary and permanent subtypes. Treatment is based on the correction of fluid-electrolyte disturbances and hyperglycemia. Patients respond to insulin or sulfonylurea treatment according to the mutation type. Close glucose monitoring and education of caregivers about diabetes are vital. |
format | Online Article Text |
id | pubmed-7315067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Kare Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-73150672020-06-25 Neonatal Diabetes Mellitus Zübarioğlu, Adil Umut Bülbül, Ali Uslu, Hasan Sinan Sisli Etfal Hastan Tip Bul Review Neonatal diabetes is a rare cause of hyperglycemia in the neonatal period. It is caused by mutations in genes that encode proteins playing critical roles in normal functions of pancreatic beta cells. Neonatal diabetes is divided into temporary and permanent subtypes. Treatment is based on the correction of fluid-electrolyte disturbances and hyperglycemia. Patients respond to insulin or sulfonylurea treatment according to the mutation type. Close glucose monitoring and education of caregivers about diabetes are vital. Kare Publishing 2018-06-07 /pmc/articles/PMC7315067/ /pubmed/32595377 http://dx.doi.org/10.14744/SEMB.2017.51422 Text en Copyright: © 2018 by The Medical Bulletin of Sisli Etfal Hospital http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/). |
spellingShingle | Review Zübarioğlu, Adil Umut Bülbül, Ali Uslu, Hasan Sinan Neonatal Diabetes Mellitus |
title | Neonatal Diabetes Mellitus |
title_full | Neonatal Diabetes Mellitus |
title_fullStr | Neonatal Diabetes Mellitus |
title_full_unstemmed | Neonatal Diabetes Mellitus |
title_short | Neonatal Diabetes Mellitus |
title_sort | neonatal diabetes mellitus |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315067/ https://www.ncbi.nlm.nih.gov/pubmed/32595377 http://dx.doi.org/10.14744/SEMB.2017.51422 |
work_keys_str_mv | AT zubariogluadilumut neonataldiabetesmellitus AT bulbulali neonataldiabetesmellitus AT usluhasansinan neonataldiabetesmellitus |